
J&J's $1.5B Talc Verdict: A Sobering Look at Corporate Risk and Liability
A jury just handed Johnson & Johnson a staggering $1.5 billion verdict in a talc cancer case. Let's break down what this massive award means and explore the huge ripple effects for corporate liability and the insurance world.










